Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 USD | -1.00% | -5.73% | -52.83% |
Financials (USD)
Sales 2022 | 22.3M | Sales 2023 | 7.19M | Capitalization | 25.42M |
---|---|---|---|---|---|
Net income 2022 | -62M | Net income 2023 | -50M | EV / Sales 2022 | 2.66 x |
Net Debt 2022 | 48.89M | Net Debt 2023 | 33.81M | EV / Sales 2023 | 8.23 x |
P/E ratio 2022 |
-0.12
x | P/E ratio 2023 |
-0.33
x | Employees | 113 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 18.78% |
Latest transcript on T2 Biosystems, Inc.
1 day | -1.00% | ||
1 week | -5.73% | ||
Current month | -1.33% | ||
1 month | -15.19% | ||
3 months | -32.73% | ||
6 months | -47.75% | ||
Current year | -52.83% |
Managers | Title | Age | Since |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 20-01-07 |
John Sprague
DFI | Director of Finance/CFO | 65 | 18-01-29 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 14-06-30 |
Seymour Liebman
BRD | Director/Board Member | 74 | 16-09-20 |
Robin Toft
BRD | Director/Board Member | 63 | 20-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 2.99 | +1.70% | 106,827 |
24-04-17 | 2.94 | -2.97% | 63,952 |
24-04-16 | 3.03 | +2.02% | 84,568 |
24-04-15 | 2.97 | -5.41% | 188,846 |
24-04-12 | 3.14 | -0.32% | 156,306 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-52.83% | 16.48M | |
+2.64% | 207B | |
+1.80% | 175B | |
+8.59% | 132B | |
+16.47% | 99.1B | |
-3.42% | 60.89B | |
+12.71% | 52.04B | |
-6.61% | 45.48B | |
-4.53% | 38.81B | |
+9.27% | 38.77B |
- Stock Market
- Equities
- TTOO Stock